Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.14 -1.81%
Revenue Growth %: +32.0%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: +32.0%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.71, $0.22 better than the analyst estimate of $0.49. Revenue for the quarter came in at $222.2 million versus the consensus estimate of $279 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
- Trump plans to request Supreme Court rehearing on birthright citizenship
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
